p53 and Ki-67 in Barrett's carcinoma: is there any value to predict recurrence after circumferential endoscopic mucosal resection?
Authors:
- César Vivian LopesCLCésar Vivian Lopes
- Hela MnifHMHela Mnif
- Christian PesentiCPChristian Pesenti
- Erwan BoriesEBErwan Bories
- Genevieve MongesGMGenevieve Monges
- Marc GiovanniniMGMarc Giovannini
Open Access
- 1 December 2007
- journal article
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 44 (4) , 304-308
Abstract
BACKGROUND: There are situations in which the specimens obtained after endoscopic mucosal resection of superficial adenocarcinoma arising from Barrett's esophagus are not adequate for histopathological assessment of the margins. In these cases, immunohistochemistry might be an useful tool for predicting cancer recurrence. AIM: To evaluate the value of p53 and Ki-67 immunohistochemistry in predicting the cancer recurrence in patients with Barrett's esophagus-related cancer referred to circumferential endoscopic mucosal resection. METHODS: Mucosectomy specimens from 41 patients were analyzed. All endoscopic biopsies prior to endoscopic mucosal resection presented high-grade dysplasia and cancer was detected in 23 of them. Positive reactions were considered the intense coloration in the nuclei of at least 90% of the cells in each high-power magnification field, and immunostaining could be classified as superficial or diffuse according to the mucosal distribution of the stained nuclei. RESULTS: Endoscopic mucosal resection samples detected cancer in 21 cases. In these cases, p53 immunohistochemistry revealed a diffuse positivity for the great majority of these cancers (90.5% vs. 20%), and Ki-67 showed a diffuse pattern for all cases (100% vs. 30%); conversely, patients without cancer revealed a superficial or negative pattern for p53 (80% vs. 9.5%) and Ki-67 (70% vs. 0%). During a mean follow-up of 31.6 months, 5 (12.2%) patients developed six episodes of recurrent cancer. Endoscopic mucosal resection specimens did not show any significant difference in the p53 and Ki-67 expression for patients developing cancer after endoscopic treatment. CONCLUSIONS: p53 and Ki-67 immunohistochemistry were useful to confirm the cancer; however, they had not value for predicting the recurrent carcinoma after circumferential endoscopic mucosal resection of Barrett's carcinoma.Keywords
This publication has 22 references indexed in Scilit:
- p53 Immunohistochemical expression in Barrett's esophagus before and after endoscopic ablation by argon plasma coagulationScandinavian Journal of Gastroenterology, 2005
- Malignant degeneration of Barrett’s esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53Diseases of the Esophagus, 2004
- p53 Gene Mutation and Protein Accumulation during Neoplastic Progression in Barrett's EsophagusLaboratory Investigation, 2001
- Biomarkers in Barrett EsophagusMayo Clinic Proceedings, 2001
- Role of p53 Assessment in Management of Barrett's EsophagusDigestive Diseases and Sciences, 1999
- Grading and scoring in histopathologyHistopathology, 1998
- Barrett's EsophagusAnnals of Surgery, 1997
- p53 protein expression in Barrett's adenocarcinoma: a frequent event with no prognostic significanceHistopathology, 1994
- p53 In tumour pathology: Can we trust immunohistochemistry?—revisited!The Journal of Pathology, 1994
- An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasmsThe Journal of Pathology, 1994